Written by the Nuvirox Research Team
Key Points
- Creatine and NAD+ precursors like nicotinamide riboside (NR) support cellular energy through two separate systems — the phosphocreatine shuttle and the mitochondrial electron transport chain.
- Human trials on creatine's cognitive and physical benefits are strong; trials on NR are strong for raising blood NAD+ but mixed on downstream performance.
- No published human trial has tested creatine plus NR together, so the stack is mechanistically reasonable but clinically unproven as a combination.
Short answer: yes, it's a mechanistically sound stack, but there's no human trial testing creatine and NAD+ precursors together — each has been studied extensively on its own, and the honest picture is that they support different parts of the cellular energy system rather than the same one.
Creatine and NAD+ supplements get grouped together in a lot of "cellular energy" marketing copy, but they don't do the same job. Understanding the difference is the whole point of this article.
What does creatine actually do?
Creatine works through the phosphocreatine (PCr) system. Muscle and brain cells store creatine as phosphocreatine, which can donate a phosphate group to ADP almost instantly, regenerating ATP without waiting for the slower mitochondrial pathways to catch up. It's a rapid energy buffer, most useful during short bursts of high demand — a heavy lift, a sprint, or (in the brain) a sudden spike in cognitive load.
A systematic review of randomized controlled trials on creatine and cognition found that short-term memory and reasoning tasks improved with supplementation in several trials, though results were inconsistent across other cognitive domains like attention and reaction time creatine is implicated in cellular energy homeostasis through the phosphocreatine/creatine system linked to adenine nucleotides via the creatine phosphokinase reaction. That's a fair, if unglamorous, summary: creatine's energy-buffering role is well established mechanistically, and cognitive benefits show up in some trials and domains but not uniformly across all of them.
What does NAD+ actually do, and how is that different?
NAD+ is a coenzyme, not a fuel buffer. It shuttles electrons through the mitochondrial electron transport chain, the slower, higher-capacity system that generates most of a cell's ATP over sustained periods. NAD+ also activates sirtuins, a family of proteins involved in mitochondrial repair and stress resilience (see our deep dive on NAD+ and autophagy for how that cleanup process works). Nicotinamide riboside (NR), the precursor in NAD+ Restore, has been shown in a pharmacokinetic dose-escalation trial to roughly double blood NAD+ levels at doses of 1,000 mg twice daily a pharmacokinetics study of NR with dose escalation over 9 days up to 1000 mg twice daily increased blood NAD+ concentrations over pretreatment levels in every subject, on average about 2-fold.
So creatine buffers short bursts; NAD+ precursors support the sustained mitochondrial engine underneath. On paper, that's complementary, not redundant.
Figure: a mechanism illustration, not a measured comparison of the two supplements' effect sizes.
Has anyone actually tested creatine and NAD+ precursors together?
No. This is the honest gap. We searched specifically for combination trials, and none exist in the published literature as of this writing. What does exist is separate, fairly robust literature on each ingredient individually, plus mechanistic reviews noting that mitochondrial modulators like NR can pair with other metabolic-support compounds along shared pathways — but that's a mechanistic argument, not a tested one nicotinamide riboside enhances cellular NAD+ pools, activating sirtuin-dependent pathways and stimulating mitochondrial biogenesis, positioning it as one of several mitochondrial modulators studied for cardiometabolic and neuroprotective potential.
If a company tells you they have a clinical trial proving a creatine-NAD+ stack "supercharges" energy, ask for the citation. As of now, that trial doesn't exist.
Where does the phosphocreatine system fall short, and where might NAD+ support pick up slack?
Phosphocreatine stores are finite and deplete within roughly 10 seconds of maximal effort. After that, cells lean on glycolysis and then oxidative phosphorylation — the NAD+-dependent pathway — to keep producing ATP. This is why creatine is most studied for explosive, short-duration output, while NAD+ status is more often discussed in the context of endurance, recovery, and age-related mitochondrial decline. If your goal is single-rep strength or sprint performance, creatine's evidence base is the stronger, more direct fit. If your goal is sustained energy across a long day, or supporting the slower mitochondrial machinery as it naturally declines with age, that's closer to the NAD+ precursor lane.
What about the honest counterweight on NAD+ precursors specifically?
It's worth being direct about a limitation that applies across the NAD+ precursor category. A well-controlled study in insulin-resistant men found that NR reliably raised NAD+ and changed mitochondrial gene expression, but did not measurably improve mitochondrial bioenergetics itself NAD+ boosters are theoretically capable of raising the NAD+/NADH ratio, and NR replenishes NAD+ stores enhancing mitochondrial function and tissue repair in animal models, though human translation of some downstream effects remains incomplete — more precisely, Elhassan YS, et al. "Nicotinamide Riboside Augments NAD+ and Improves Mitochondrial Gene Expression but Does Not Alter Mitochondrial Bioenergetics in Muscle of Insulin-Resistant Men." Cell Reports 2019;28(7):1717-1728. PMID: 31412242. That's the fair reading: raising the raw material (NAD+) doesn't automatically translate into a measurable jump in how efficiently mitochondria burn fuel, at least not within the timeframes tested so far.
Study Snapshot: Creatine and Cognition (Systematic Review)
What Nuvirox's own product does and doesn't claim here
NAD+ Restore is formulated around NR, resveratrol, and quercetin — it isn't marketed as a creatine replacement or a combination product, and we're not suggesting the two need to be taken together. If you already use creatine for training, adding an NAD+ precursor targets a different, complementary system rather than duplicating what creatine already does. The resveratrol and quercetin included alongside NR are studied as polyphenols alongside NAD+ pathways for general cellular health support, not as performance ingredients competing with creatine's specific phosphocreatine mechanism.
Dosing and timing, grounded in what's actually been tested
Creatine monohydrate is most commonly studied at 3–5 g daily, with or without a loading phase. NR has been tested up to 1,000 mg twice daily in pharmacokinetic work, though most consumer NAD+ supplements, including NAD+ Restore, use more moderate daily doses (500 mg NR per two-capsule serving) consistent with longer-term tolerability data. Neither ingredient requires cycling; both are typically taken daily with food.
Frequently asked questions
Will taking creatine cancel out an NAD+ supplement, or vice versa?
No mechanism in the literature suggests one interferes with the other. They act on different systems (phosphocreatine shuttle vs. electron transport chain), so there's no known antagonism — but also no trial confirming a synergistic boost beyond what each does alone.
Should I take them at the same time of day?
There's no research dictating timing for the combination specifically. Most people take creatine post-workout or with a meal, and NAD+ precursors like NR with breakfast; that's a matter of routine, not a documented requirement.
Is creatine also an NAD+ precursor?
No. Creatine and NAD+ are chemically unrelated compounds. Creatine is a nitrogen-containing organic acid; NAD+ is a dinucleotide coenzyme. They're often shelved together in "cellular energy" categories, which can blur the distinction.
Does age change which one matters more?
NAD+ levels are well-documented to decline with age, which is the rationale behind precursor supplementation later in life. Creatine's benefits appear fairly consistent across age groups, though some research suggests older adults may see modestly larger cognitive effects, in line with general creatine-cognition findings.
The bottom line
Creatine and NAD+ precursors are not competing products, and they're not proven partners either — they're two independently well-studied compounds that happen to both get filed under "cellular energy." If you want fast-twitch, short-burst performance, creatine has the deeper trial base. If you're interested in supporting the slower mitochondrial and repair pathways that decline with age, that's the NAD+ precursor lane, discussed in more depth in our piece on what NAD+ benefits are actually supported by human evidence. Stacking them is reasonable on mechanism; just don't expect a clinical trial to back up the combination claim, because none exists yet.
From Nuvirox
Why we formulated NAD+ Restore
Each two-capsule serving delivers 500 mg of nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials — alongside 150 mg trans-resveratrol and 50 mg quercetin, polyphenols studied alongside NAD+ pathways for cellular health support. We add 10 mg of galactomannans from fenugreek to support absorption.
Backed by a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →References
- Systematic review of RCTs: "Effects of creatine supplementation on cognitive function of healthy individuals." PMCID: PMC6093191.
- Pharmacokinetic dose-escalation study of NR (NCT02689882): up to 1000 mg twice daily increased blood NAD+ ~2-fold on average, well tolerated.
- Elhassan YS, et al. "Nicotinamide Riboside Augments NAD+ and Improves Mitochondrial Gene Expression but Does Not Alter Mitochondrial Bioenergetics in Muscle of Insulin-Resistant Men." Cell Reports 2019;28(7):1717-1728. PMID: 31412242.
- "Mitochondrial Health Through Nicotinamide Riboside and Berberine: Shared Pathways and Therapeutic Potential." PMCID: PMC12786874.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.